共 149 条
- [1] Varghese R(2023)Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern? Hum Cell 36 1218-1221
- [2] Kumar D(2023)Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022 Euro Surveill 28 2300008-286.e8
- [3] Sharma R(2023)Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants Cell 186 279-1555
- [4] Novazzi F(2022)Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant Cell Host Microbe 30 1540-4007
- [5] Giombini E(2022)Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5 Cell 185 3992-124
- [6] Rueca M(2023)Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant Nat Commun 14 2671-676
- [7] Baj A(2022)Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19 Nat Commun 13 6025-495
- [8] Fabeni L(2023)SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies Nat Rev Microbiol 21 112-e197
- [9] Genoni A(2022)Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Lancet 399 665-710
- [10] Wang Q(2023)Substantial neutralization escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 N Engl J Med 387 86-2963